BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
TGFB1
,
Apoptosis
,
Breast Cancer
,
Retina
,
Holistic medicine
,
Acetaminophen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tumors unknown origins
Summary
General Info
Curated Studies
Most Correlated Studies
Mouse genetic models of neurofibromatosis tumors
Antioxidant response element activation by DPP3 or SQSTM1 in IMR-32 neuroblastoma cells
Pilocytic astrocytomas from multiple CNS origins and with different MAPK mutations
OMIM - Neoplasm of brain
Craniopharyngiomas, choroid plexus papillomas and medulloblastomas from pediatric patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Laparoscopic Surgery for a Patient With Multiple Liver Metastases of Unknown Origin Concomitant With…
Differences in outcomes of bilateral adrenalectomy in patients with ectopic ACTH producing tumor of …
Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based exper…
Pituitary stalk metastasis of a neuroendocrine tumour of unknown origin.
CRE24-051: Rare Case of a Paraneoplastic Cerebellar Ataxia Secondary to a Retroperitoneal Neuroendoc…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ